Article
Zidovudine susceptibility testing of human immunodeficiency virus type 1 (HIV) clinical isolates.
Journal of virological methods - 1 Mar 1993
Shafer R W, Kozal M J, Katzenstein D A, Lipil W H, Johnstone I F, Merigan T C
Abstract excerpt
Traditional antiviral susceptibility testing methods using cell lines can be applied to no more than about 30% of clinical HIV isolates (Larder et al., 1989a; Fenyo et al., 1989). We tested the cell-free supernatant from low passage clinical HIV isolates using donor peripheral blood mononuclear cells (PBMC). Drug susceptibility was assessed by measuring the effect of increasing zidovudine (ZDV) concentrations on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
